FRM-0334
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FRM-0334, covering 2016-03-23 to 2016-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation [Phase 2]